Living with RA Is Hard, but Actemra Makes It Worse
Millions of people across the United States suffer from constant pain from Rheumatoid Arthritis. It makes doing activities like taking a vacation extremely difficult. Consumers depend on medications like Actemra to help them lead a normal life. However, when companies like Roche, the maker of Actemra, fail to warn about the dangers of their medication, it destroys
Read MoreActemra & Psoriasis
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including psoriasis, stroke, heart attack and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over 1.5 million Americans
Read MoreActemra & Pruritus
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including pruritus, stroke, heart attack and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over 1.5 million Americans
Read MoreActemra & Demyelination
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including demyelination, stroke, heart attack and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over 1.5 million Americans
Read MoreActemra & Interstitial Lung Disease
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including interstitial lung disease (ILD), stroke, heart attack and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over
Read MoreActemra & Meniscus
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including meniscus tears, stroke, heart attack and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over 1.5 million
Read MoreActemra & Synovitis
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including Synovitis, stroke, heart attack and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over 1.5 million Americans
Read MoreActemra & Lumbar Spinal Stenosis
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including Lumbar Spinal Stenosis, stroke, heart attack and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over 1.5
Read MoreActemra & Endocarditis
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including endocarditis, stroke, interstitial lung disease, and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over 1.5 million
Read MoreActemra & Heart Failure
Studies have linked the rheumatoid arthritis drug Actemra (tocilizumab injection) to serious side effects including heart failure, stroke, interstitial lung disease, and more than 1,100 deaths. About Actemra In early 2010, the FDA first approved the Roche manufactured drug, Actemra to treat moderate to severe rheumatoid arthritis (RA). The drug works by reducing inflammation. Over 1.5
Read More